• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form F-3/A filed by Canaan Inc.

    9/3/24 8:00:29 AM ET
    $CAN
    Semiconductors
    Technology
    Get the next $CAN alert in real time by email
    F-3/A 1 tm2423211-1_f3a.htm F-3/A tm2423211-1_f3a - none - 2.1718852s
    ​
    As filed with the Securities and Exchange Commission on September 3, 2024
    Registration No. 333-278762​
    ​
    ​
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ​
    AMENDMENT NO. 1
    TO
    FORM F-3
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933
    ​
    Canaan Inc.
    (Exact name of Registrant as specified in its charter)
    ​
    Not Applicable
    (Translation of Registrant’s name into English)
    ​
    ​
    Cayman Islands
    (State or other jurisdiction of
    incorporation or organization)​
    ​ ​
    Not Applicable
    (I.R.S. Employer
    Identification Number)
    ​
    28 Ayer Rajah Crescent
    #06-08
    Singapore 139959
    (Address and telephone number of Registrant’s principal executive offices)
    ​
    Cogency Global Inc.
    122 East 42nd Street, 18th Floor
    New York, New York 10168
    +1-212-947-7200
    (Name, address, and telephone number of agent for service)
    ​
    Copies to:
    Justin You Zhou, Esq.
    Kirkland & Ellis International LLP
    c/o 26th Floor, Gloucester Tower
    The Landmark
    15 Queen’s Road Central,
    Hong Kong
    +852-3761-3318
    ​
    Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.
    ​
    If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐
    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒
    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
    Emerging growth company ☒​
    If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐
    The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
    ​
    †
    The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.
    ​
    ​
    ​

    ​
     
    EXPLANATORY NOTE
    This Amendment No. 1 to the Registration Statement on Form F-3, or the Registration Statement, is being filed solely for the purpose of filing exhibit 23.1, the consent of KPMG Huazhen LLP, to this Registration Statement, and to amend and restate the exhibit index set forth in Part II of the Registration Statement. No other changes have been made to the Registration Statement or its cover page. This Amendment No. 1 does not contain a copy of the prospectus included in the Registration Statement, which remains unchanged from the Registration Statement filed on April 17, 2024.
     
    1

    ​
     
    PART II
    INFORMATION NOT REQUIRED IN PROSPECTUS
    ITEM 8.   INDEMNIFICATION OF DIRECTORS AND OFFICERS
    The Cayman Companies Act does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against dishonesty, willful default or fraud or the consequences of committing a crime. Our articles of association provide that we shall indemnify our officers and directors against all actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by such directors or officer, other than by reason of such person’s dishonesty, willful default or fraud, in or about the conduct of our company’s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning our company or its affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition, we intend to enter into indemnification agreements with our directors and executive officers that will provide such persons with additional indemnification beyond that provided in our articles of association.
    Under the indemnification agreements with our directors and executive officers, the form of which was filed as Exhibit 10.2 to our registration statement on Form F-1, as amended (File No. 333-234356), we have agreed to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being such a director or executive officer.
    Any underwriting agreement entered into in connection with an offering of our securities may also provide for indemnification of us and our officers and directors in certain cases.
    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
    We also maintain a directors and officers liability insurance policy for our directors and officers.
    ITEM 9.   EXHIBITS
    See Exhibit Index beginning on page II-4 of this registration statement.
    ITEM 10.   UNDERTAKINGS.
    (a)   The undersigned registrant hereby undertakes:
    (1)   To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
    (i)   To include any prospectus required by Section 10(a)(3) of the Securities Act;
    (ii)   To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
    (iii)   Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
     
    II-1

    ​
     
    (iv)   To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
    provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this item do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
    (2)   That, for the purpose of determining any liability under the Securities Act, each such post- effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (3)   To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
    (4)   To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Securities Act or Item 8.A of Form 20-F if such financial statements and information are contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement.
    (5)   That, for the purpose of determining liability under the Securities Act to any purchaser:
    (i)   Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
    (ii)   Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
    (6)   That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities:
    The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such
     
    II-2

    ​
     
    purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
    (i)   Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
    (ii)   Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
    (iii)   The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
    (iv)   Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
    (b)   The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (c)   Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
     
    II-3

    ​
     
    EXHIBIT INDEX
    ​
    Exhibit
    Number
    ​ ​
    Description
    ​
    ​
    1.1*
    ​ ​ Form of Underwriting Agreement ​
    ​
    4.1
    ​ ​
    Registrant’s Specimen American Depositary Receipt evidencing American Depositary Shares (included in Exhibit 4.3).
    ​
    ​
    4.2
    ​ ​ Registrant’s Specimen of Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to the registration statement on Form F-1 (File No. 333-234356), as amended, initially filed with the Securities and Exchange Commission on October 28, 2019) ​
    ​
    4.3
    ​ ​ Form of Deposit Agreement by and among the Registrant, the depositary and the holders and beneficial owners of the American Depositary Receipts issued thereunder (incorporated by reference to Exhibit 1 to the registration statement on Form F-6 (File No. 333-234510), filed with the Securities and Exchange Commission on November 5, 2019) ​
    ​
    4.4*
    ​ ​ Certificate of Designation for Preferred Shares ​
    ​
    4.5*
    ​ ​ Registrant’s Specimen of Warrant Certificate ​
    ​
    4.6*
    ​ ​ Form of Warrant Agreement ​
    ​
    4.7*
    ​ ​ Form of Indenture ​
    ​
    4.8*
    ​ ​ Form of Debt Security ​
    ​
    4.9*
    ​ ​ Form of Subscription Rights Agreement ​
    ​
    4.10*
    ​ ​ Form of Subscription Rights Certificate ​
    ​
    4.11*
    ​ ​ Specimen Unit Certificate ​
    ​
    5.1†
    ​ ​
    Opinion of Maples and Calder (Hong Kong) LLP regarding the validity of the securities being registered
    ​
    ​
    8.1†
    ​ ​
    Opinion of Maples and Calder (Hong Kong) LLP regarding certain Cayman Islands tax matters (included in Exhibit 5.1)
    ​
    ​
    8.2†
    ​ ​
    Opinion of Commerce & Finance Law Officers regarding certain PRC law matters
    ​
    ​
    23.1**
    ​ ​
    Consent of KPMG Huazhen LLP, Independent Registered Public Accounting Firm
    ​
    ​
    23.2†
    ​ ​
    Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit 5.1)
    ​
    ​
    23.3†
    ​ ​
    Consent of Commerce & Finance Law Officers
    ​
    ​
    24.1†
    ​ ​
    Power of attorney (included on signature page hereof)
    ​
    ​
    107†
    ​ ​
    Calculation of Filing Fee Table
    ​
    ​
    *
    To be filed as an exhibit to a post-effective amendment to this registration statement or as an exhibit to a report filed or furnished under the Exchange Act and incorporated by reference.
    ​
    **
    Filed with this registration statement on Form F-3.
    ​
    †
    Previously filed.
    ​
     
    II-4

    ​
     
    SIGNATURES
    Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Singapore, on September 3, 2024.
    CANAAN INC.
    By:
    /s/ Nangeng Zhang
    ​
    ​
    Name:
    Nangeng Zhang
    ​
    Title:
    Chairman and Chief Executive Officer
    ​
     
    II-5

    ​
     
    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Mr. Nangeng Zhang as his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and sign any registration statement for the same offering covered by this registration statement that is to be effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act of 1933, as amended, and all post-effective amendments thereto and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitutes or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act, the registration statement has been signed by the following persons on September 3, 2024 in the capacities indicated.
    ​
    Signature
    ​ ​
    Title
    ​
    ​
    /s/ Nangeng Zhang
    ​
    Name: Nangeng Zhang
    ​ ​
    Chairman and Chief Executive Officer (principal executive officer)
    ​
    ​
    *
    ​
    Name: Wenjun Zhang
    ​ ​
    Independent Director
    ​
    ​
    *
    ​
    Name: Hongchao Du
    ​ ​
    Independent Director
    ​
    ​
    *
    ​
    Name: Zhitang Shu
    ​ ​
    Independent Director
    ​
    ​
    *
    ​
    Name: Yaping Zhang
    ​ ​
    Independent Director
    ​
    ​
    *
    ​
    Name: James Jin Cheng
    ​ ​
    Chief Financial Officer
    ​
    ​
    *
    ​
    Name: Lu Meng
    ​ ​
    Secretary to the Board
    ​
    ​
    By:
    /s/ Nangeng Zhang
    ​
    ​
    Nangeng Zhang
    Attorney-in-Fact
     
    II-6

    ​
     
    SIGNATURE OF AUTHORIZED REPRESENTATIVE OF THE REGISTRANT
    Pursuant to the requirements of the Securities Act, the undersigned, the duly authorized representative in the United States of Canaan Inc. has signed this registration statement or amendment thereto in New York, United States on September 3, 2024.
    Authorized U.S. Representative
    Cogency Global Inc.
    By:
    /s/ Colleen A. De Vries
    ​
    ​
    Name:
    Colleen A. De Vries
    ​
    Title:
    Senior Vice President on behalf of
    Cogency Global Inc.
    ​
     
    II-7

    Get the next $CAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAN

    DatePrice TargetRatingAnalyst
    12/8/2025$3.00Buy
    BTIG Research
    9/15/2025Buy
    Compass Point
    6/18/2025$1.50Market Perform
    Northland Capital
    5/6/2025$3.00Buy
    The Benchmark Company
    3/18/2025$2.50Buy
    Compass Point
    9/18/2024$2.00Buy
    B. Riley Securities
    9/11/2024$3.00Buy
    Rosenblatt
    7/6/2022$5.00Buy
    H.C. Wainwright
    More analyst ratings

    $CAN
    SEC Filings

    View All

    SEC Form 6-K filed by Canaan Inc.

    6-K - Canaan Inc. (0001780652) (Filer)

    2/10/26 8:56:24 AM ET
    $CAN
    Semiconductors
    Technology

    SEC Form 6-K filed by Canaan Inc.

    6-K - Canaan Inc. (0001780652) (Filer)

    2/10/26 8:55:02 AM ET
    $CAN
    Semiconductors
    Technology

    SEC Form 6-K filed by Canaan Inc.

    6-K - Canaan Inc. (0001780652) (Filer)

    1/16/26 9:14:43 AM ET
    $CAN
    Semiconductors
    Technology

    $CAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Canaan Inc. Provides January 2026 Bitcoin Production and Mining Operation Updates

    Achieved record high cryptocurrency treasury of 1,778 BTC and 3,951 ETH Deployed global hashrate exceeded 10 EH/s SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending January 31, 2026. Management Commentary "Our results for January 2026 demonstrate the resilience and adaptability of our global mining operations," said Nangeng Zhang, chairman and CEO of Canaan. "Despite macroeconomic headwinds and record winter storms across North America, our operational discipline allowed us to increase our bitcoin balance. As part of our joint mining arrangement

    2/10/26 6:31:00 AM ET
    $CAN
    Semiconductors
    Technology

    Canaan Inc. Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Total revenues achieved US$196.3 million, up 121.1% YoY Bitcoin mining revenues reached US$30.4 million, up 98.5% YoY Cryptocurrency treasury[1] climbed to a record 1,750 BTC and 3,951 ETH as of December 31, 2025 Generated quarterly gross profit of US$14.6 million and annual gross profit of US$41.2 million Achieved record 14.6 EH/s quarterly computing power sold, reaching 36.5 EH/s in 2025 SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Operating and Financial Highlights Total revenues 

    2/10/26 6:30:00 AM ET
    $CAN
    Semiconductors
    Technology

    Canaan Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

    SINGAPORE, Feb. 3, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today announced that it plans to report its financial results for the fourth quarter and full year ended December 31, 2025, before the U.S. market opens on February 10, 2026. The Company's management team will hold a conference call at 8:00 A.M. U.S. Eastern Time/9:00 P.M. Singapore Time on February 10, 2026, to discuss the financial results. Details for the conference call are as follows: Event Title: Canaan Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call Registration Link: https://register-conf.media-server.com/register/BIced319ec0cb74f199f256c63833a

    2/3/26 9:05:00 AM ET
    $CAN
    Semiconductors
    Technology

    $CAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Canaan with a new price target

    BTIG Research initiated coverage of Canaan with a rating of Buy and set a new price target of $3.00

    12/8/25 8:33:41 AM ET
    $CAN
    Semiconductors
    Technology

    Compass Point resumed coverage on Canaan

    Compass Point resumed coverage of Canaan with a rating of Buy

    9/15/25 7:53:17 AM ET
    $CAN
    Semiconductors
    Technology

    Northland Capital initiated coverage on Canaan with a new price target

    Northland Capital initiated coverage of Canaan with a rating of Market Perform and set a new price target of $1.50

    6/18/25 9:14:15 AM ET
    $CAN
    Semiconductors
    Technology

    $CAN
    Financials

    Live finance-specific insights

    View All

    Canaan Inc. Reports Unaudited Fourth Quarter and Full Year 2022 Financial Results

    - Achieves Record-high Bitcoin Mining Computing Power of 3.8EH/s Installed as of February-end 2023 - BEIJING, March 7, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial results for the three months and twelve months ended December 31, 2022. Fourth Quarter 2022 Operating and Financial Highlights Total computing power sold was 1.9 million Thash/s, representing a decrease of 45.8% from 3.5 million Thash/s in the third quarter of 2022 and a decrease of 75.8% from 7.7 million Thash/s in the same period of 2021. Revenues were RMB391.9 million (US$56.8 million), representing a d

    3/7/23 5:15:00 AM ET
    $CAN
    Semiconductors
    Technology

    Canaan Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

    BEIJING, Feb. 23, 2023 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it plans to report its financial results for the fourth quarter and full year ended December 31, 2022, before the U.S. market opens on March 7, 2023. The Company's management team will hold a conference call at 8:00 A.M. on March 7, 2023, U.S. Eastern Time (9:00 P.M. on the same day, Beijing Time) to discuss the financial results. Details for the conference call are as follows: Event Title:                           Canaan Inc. Fourth Quarter and Full Year 2022 Earnings Conference CallRegistration Link:                 http

    2/23/23 5:00:00 AM ET
    $CAN
    Semiconductors
    Technology

    Canaan Inc. Reports Unaudited Third Quarter 2022 Financial Results

    BEIJING, Nov. 14, 2022 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial results for the three months ended September 30, 2022. Third Quarter 2022 Operating and Financial Highlights Total computing power sold was 3.5 million Thash/s, representing a decrease of 37.1% from 5.5 million Thash/s in the second quarter of 2022 and a decrease of 48.5% from 6.7 million Thash/s in the same period of 2021. Revenues were RMB978.2 million (US$137.5 million), representing a decrease of 40.8% from RMB1,652.7 million in the second quarter of 2022 and a decrease of 25.8% from RMB1,317.6 millio

    11/14/22 3:30:00 AM ET
    $CAN
    Semiconductors
    Technology

    $CAN
    Leadership Updates

    Live Leadership Updates

    View All

    Global Technology Leader Chris Boult Joins U.S. Urology Partners as Chief Information Officer

    U.S. Urology Partners announced today that internationally recognized technology leader Chris Boult has joined the company as Chief Information Officer. U.S. Urology Partners is one of the nation's largest independent providers of urological and related specialty services, including general urology, surgical and robotic procedures, advanced cancer treatment and other ancillary services. Boult will lead information technology strategy and initiatives for the rapidly growing U.S. Urology Partners clinical network which now consists of more than 50 locations throughout the East Coast and Midwest. U.S. Urology Partners partnered with NMS Capital in 2018 to support urology practices in communi

    7/30/24 6:39:00 AM ET
    $CAN
    $SABR
    Semiconductors
    Technology
    Computer Software: Programming Data Processing

    Canaan Announces Change of Auditor

    BEIJING, Sept. 13, 2021 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced that it has dismissed PricewaterhouseCoopers Zhong Tian LLP ("PwC") as the Company's independent auditor on September 9, 2021 and has approved the appointment of KPMG Huazhen LLP ("KPMG") as the independent auditor of the Company, effective September 13, 2021. The change of the Company's independent auditor was made after careful consideration and evaluation process and was approved by the Audit Committee and the Board of Directors of the Company. The reports of PwC on the Company's consolidated financial statements as of and f

    9/13/21 11:15:00 PM ET
    $CAN
    Semiconductors
    Technology

    Canaan Announces Appointment of Chief Financial Officer

    BEIJING, Aug. 2, 2021 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced the appointment of Mr. James Jin Cheng to the position of Chief Financial Officer, effective immediately. Mr. Tong He will cease to serve as the Company's acting Chief Financial Officer but will maintain his position as the Company's Director of Finance. Mr. Cheng has more than 20 years of experience in financial planning and management. Prior to joining Canaan, Mr. Cheng served as a Vice President for Zhaopin.com, a career platform in China formerly listed on the NYSE, from September 2015 to July 2021. Between September 2013 to

    8/2/21 7:00:00 AM ET
    $CAN
    Semiconductors
    Technology

    $CAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Canaan Inc.

    SC 13G/A - Canaan Inc. (0001780652) (Subject)

    10/24/24 2:46:52 PM ET
    $CAN
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by Canaan Inc. (Amendment)

    SC 13G/A - Canaan Inc. (0001780652) (Subject)

    2/8/24 8:02:10 PM ET
    $CAN
    Semiconductors
    Technology

    SEC Form SC 13G filed by Canaan Inc.

    SC 13G - Canaan Inc. (0001780652) (Subject)

    12/20/23 11:48:48 AM ET
    $CAN
    Semiconductors
    Technology